共 182 条
[1]
Yamamoto Y(2007)Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer Eur J Nucl Med Mol Imaging 34 1610-1616
[2]
Nishiyama Y(2007)18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients J Nucl Med 48 726-735
[3]
Ishikawa S(2005)Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods Cancer Res 65 10104-10112
[4]
Nakano J(2002)In vivo validation of 3′deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors Clin Cancer Res 8 3315-3323
[5]
Chang SS(2003)3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography Cancer Res 63 3791-3798
[6]
Bandoh S(2007)FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3′-deoxy-3′-[18F]fluorothymidine Semin Nucl Med 37 429-439
[7]
Troost EG(2003)[18F]FLT PET for diagnosis and staging of thoracic tumours Eur J Nucl Med Mol Imaging 30 1407-1412
[8]
Vogel WV(2008)Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer Eur J Nucl Med Mol Imaging 35 236-245
[9]
Merkx MA(2003)Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG J Nucl Med 44 1426-1431
[10]
Slootweg PJ(2004)Is 18F-3′-fluoro-3′-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer? J Nucl Med 45 1677-1682